- Home
- ALTG vs ACIU Comparison
ALTG vs ACIU Comparison
Compare ALTG & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTG
- ACIU
- Stock Information
- Founded
- ALTG 1984
- ACIU 2003
- Country
- ALTG United States
- ACIU Switzerland
- Employees
- ALTG N/A
- ACIU N/A
- Industry
- ALTG Industrial Machinery/Components
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- ALTG Industrials
- ACIU Health Care
- Exchange
- ALTG Nasdaq
- ACIU Nasdaq
- Market Cap
- ALTG 247.6M
- ACIU 213.3M
- IPO Year
- ALTG N/A
- ACIU 2016
- Fundamental
- Price
- ALTG $8.56
- ACIU $2.28
- Analyst Decision
- ALTG Hold
- ACIU Strong Buy
- Analyst Count
- ALTG 3
- ACIU 1
- Target Price
- ALTG $11.67
- ACIU $12.00
- AVG Volume (30 Days)
- ALTG 254.6K
- ACIU 122.7K
- Earning Date
- ALTG 08-07-2025
- ACIU 11-04-2025
- Dividend Yield
- ALTG 2.66%
- ACIU N/A
- EPS Growth
- ALTG N/A
- ACIU N/A
- EPS
- ALTG N/A
- ACIU N/A
- Revenue
- ALTG $1,851,100,000.00
- ACIU $36,362,036.00
- Revenue This Year
- ALTG $1.30
- ACIU N/A
- Revenue Next Year
- ALTG $3.26
- ACIU $1,022.98
- P/E Ratio
- ALTG N/A
- ACIU N/A
- Revenue Growth
- ALTG N/A
- ACIU 86.71
- 52 Week Low
- ALTG $3.54
- ACIU $1.43
- 52 Week High
- ALTG $8.99
- ACIU $3.98
- Technical
- Relative Strength Index (RSI)
- ALTG 59.82
- ACIU 57.11
- Support Level
- ALTG $7.99
- ACIU $2.12
- Resistance Level
- ALTG $8.88
- ACIU $2.32
- Average True Range (ATR)
- ALTG 0.36
- ACIU 0.12
- MACD
- ALTG 0.02
- ACIU 0.01
- Stochastic Oscillator
- ALTG 79.94
- ACIU 78.13
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.